Personality Differences between Drug Injectors and Non-injectors among Substance-Dependent Patients in Substitution Treatment

REFERENCES

• Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B, and the SerT Study Group. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Ann Ist Super Sanita 2010; 46(1):59–65.
   PubMed Web of Science ®Google Scholar
• Fischer B, Manzoni P, Rehm J. Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN cohort). Eur Addict Res 2006; 12(4):230–239.
   PubMed Web of Science ®Google Scholar
• Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study. Drug Alcohol Depend 2002; 66(2):189–198.
   PubMed Web of Science ®Google Scholar
• Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992; 87(11):1527–1536.
   PubMedGoogle Scholar
• Strang J, Bearn J, Farrell M, Finch E, Gossop M, Griffiths P, Marsden J, Wolff K. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev 1998; 17(2):197–211.
   PubMed Web of Science ®Google Scholar
• Dunn J, Laranjeira RR. Transitions in the route of cocaine administration – characteristics, direction and associated variables. Addiction 1999; 94(6):813–824.
   PubMed Web of Science ®Google Scholar
• Neaigus A, Miller M, Friedman SR, Hagen L, Sifaneck SJ, Ildefonso G, Des Jarlais DC. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction 2001; 96(6):847–860.
   PubMed Web of Science ®Google Scholar
• Trull TJ, Durrett CA. Categorical and dimensional models of personality disorder. Annu Rev Clin Psychol 2005; 1:355–380.
   PubMed Web of Science ®Google Scholar
• Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C. Personality disorders in drug abusers: Prevalence and their association with axis I disorders as predictors of treatment retention. Addict Behav 1998; 23(6):841–853.
   PubMed Web of Science ®Google Scholar
• Acton GS. Measurement of impulsivity in a hierarchical model of personality traits: Implications for substance use. Subst Use Misuse 2003; 38:67–83.
   PubMed Web of Science ®Google Scholar
• Hyler SE. Personality Questionnaire (PDQ-4+). New York, NY: New York State Psychiatric Institute, 1994.
   Google Scholar
• Bowden-Jones O, Iqbal MZ, Tyrer P, Seivewright N, Cooper S, Judd A, Weaver T, on behalf on the COSMIC study team. Prevalence of personality disorder in alcohol and drug services and associated comorbidity. Addiction 2004; 99(10):1306–1314.
   PubMed Web of Science ®Google Scholar
• Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry 1999; 156(5):733–738.
   PubMed Web of Science ®Google Scholar
• Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005; 24(5):411–418.
   PubMed Web of Science ®Google Scholar
• Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry 2001; 16(5):274–282.
   PubMed Web of Science ®Google Scholar
• Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004; 23(2):177–183.
   PubMed Web of Science ®Google Scholar
• Fieldman NP, Woolfolk RL, Allen LA. Dimensions of self-concept: A comparison of heroin and cocaine addicts. Am J Drug Alcohol Abuse 1995; 21(3):315–326.
   PubMed Web of Science ®Google Scholar
• Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987; 44(6):573–588.
   PubMed Web of Science ®Google Scholar
• Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50(12):975–990.
   PubMed Web of Science ®Google Scholar
• Bobes J, McCann UD. Developments in the treatment of drug dependence. Curr Opin Psychiatry 2000; 13:333–338.
   Web of Science ®Google Scholar
• Conway KP, Kane RJ, Ball SA, Poling JC, Rounsaville BJ. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend 2003; 71(1):65–75.
   PubMed Web of Science ®Google Scholar
• Allnutt S, Wedgwood L, Wilhelm K, Butler T. Temperament, substance use and psychopathology in a prisoner population: Implications for treatment. Aust N Z J Psychiatry 2008; 42(11):969–975.
   PubMed Web of Science ®Google Scholar
• Evren C, Evren B, Yancar C, Erkiran M. Temperament and character model of personality profile of alcohol- and drug dependent inpatients. Compr Psychiatry 2007; 48(3):283–288.
   PubMed Web of Science ®Google Scholar
• Le Bon O, Basiaux P, Streel E, Tecco J, Hanak C, Hansenne M, Ansseau M, Pelc I, Verbanck P, Dupont S. Personality profile and drug of choice: A multivariate analysis using Cloninger’s TCI on heroin addicts, alcoholics, and a random population group. Drug Alcohol Depend 2004; 73(2):175–182.
   PubMed Web of Science ®Google Scholar
• Fossati A, Maffei C, Bagnato M, Donati D, Fiorilli M, Novella L, Ansoldi M. Brief communication: Criterion validity of the Personality Diagnostic Questionnaire-4+ (PDQ-4+) in a mixed psychiatric sample. J Personal Disord 1998; 12(2):172–178.
   PubMed Web of Science ®Google Scholar
• Watzke AB, Schmidt CO, Zimmermann J, Preuss UW. Personality disorders in a clinical sample of Cannabis dependent young adults. Fortschr Neurol Psychiatr 2008; 76(10):600–605.
   PubMed Web of Science ®Google Scholar
• Brooner RK, King VL, Kidorf M, Schmidt CW, Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997; 54(1):71–80.
   PubMed Web of Science ®Google Scholar
• Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, Kivlahan DR. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 2002; 67:3–26.
   Web of Science ®Google Scholar